Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Average-Risk Patients: Results From a Prospective, Randomized, Placebo-Controlled Trial

被引：0
|
作者：
Levenick, John M. [1 ]
Gordon, Stuart R. [2 ]
Fadden, Linda [2 ]
Rockacy, Matthew [2 ]
Hyder, Sarah [2 ]
Lacy, Brian E. [2 ]
Bensen, Steven [2 ]
Parr, Douglas [2 ]
Gardner, Timothy B. [2 ]
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01477
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1477
引用
收藏
页码：S636 / S636
页数：1
相关论文
共 50 条
  • [31] A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction
    Siddiqui, Ali A.
    Patel, Devi
    Kaplan, Jeremy
    Zabolotsky, Andrew H.
    Loren, David
    Kowalski, Thomas
    Ghumman, Saad S.
    Adler, Douglas G.
    Munigal, Satish
    Hayat, Umar
    Eloubeidi, Mohamad A.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (08) : 2509 - 2515
  • [32] A prospective, randomized, double-blind, placebo-controlled trial of transdermal glyceryl trinitrate in technical success of ERCP and the prevention of post-ERCP pancreatitis: Preliminary results
    Kaffes, A
    Alrubaie, A
    Ding, S
    Williams, S
    Bourke, M
    GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB191 - AB191
  • [33] Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk and average-risk population: A systematic review and meta-analysis
    He, Xingkang
    Zheng, Wenfang
    Ding, Yue
    Wu, Wenrui
    Sun, Lei-Min
    Si, Jianmin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 237 - 238
  • [34] Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials
    Shi, Na
    Deng, Lihui
    Altaf, Kiran
    Huang, Wei
    Xue, Ping
    Xia, Qing
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (03): : 236 - 240
  • [35] Fluid hydration to prevent post-ERCP pancreatitis in average-to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial
    Smeets, Xavier J. N. M.
    da Costa, David W.
    Fockens, Paul
    Mulder, Chris J. J.
    Timmer, Robin
    Kievit, Wietske
    Zegers, Marieke
    Bruno, Marco J.
    Besselink, Marc G. H.
    Vleggaar, Frank P.
    van der Hulst, Rene W. M.
    Poen, Alexander C.
    Heine, Gerbrand D. N.
    Venneman, Niels G.
    Kolkman, Jeroen J.
    Baak, Lubbertus C.
    Romkens, Tessa E. H.
    van Dijk, Sven M.
    Hallensleben, Nora D. L.
    van de Vrie, Wim
    Seerden, Tom C. J.
    Tan, Adriaan C. I. T. L.
    Voorburg, Annet M. C. J.
    Poley, Jan-Werner
    Witteman, Ben J.
    Bhalla, Abha
    Hadithi, Muhammed
    Thijs, Willem J.
    Schwartz, Matthijs P.
    Vrolijk, Jan Maarten
    Verdonk, Robert C.
    van Delft, Foke
    Keulemans, Yolande
    van Goor, Harry
    Drenth, Joost P. H.
    van Geenen, Erwin J. M.
    TRIALS, 2018, 19
  • [36] Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial
    Xavier J. N. M. Smeets
    David W. da Costa
    Paul Fockens
    Chris J. J. Mulder
    Robin Timmer
    Wietske Kievit
    Marieke Zegers
    Marco J. Bruno
    Marc G. H. Besselink
    Frank P. Vleggaar
    Rene W. M. van der Hulst
    Alexander C. Poen
    Gerbrand D. N. Heine
    Niels G. Venneman
    Jeroen J. Kolkman
    Lubbertus C. Baak
    Tessa E. H. Römkens
    Sven M. van Dijk
    Nora D. L. Hallensleben
    Wim van de Vrie
    Tom C. J. Seerden
    Adriaan C. I. T. L. Tan
    Annet M. C. J. Voorburg
    Jan-Werner Poley
    Ben J. Witteman
    Abha Bhalla
    Muhammed Hadithi
    Willem J. Thijs
    Matthijs P. Schwartz
    Jan Maarten Vrolijk
    Robert C. Verdonk
    Foke van Delft
    Yolande Keulemans
    Harry van Goor
    Joost P. H. Drenth
    Erwin J. M. van Geenen
    Trials, 19
  • [37] Erratum to: A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction
    Ali A. Siddiqui
    Devi Patel
    Jeremy Kaplan
    Andrew H. Zabolotsky
    David Loren
    Thomas Kowalski
    Saad S. Ghumman
    Douglas G. Adler
    Satish Munigala
    Umar Hayat
    Mohamad A. Eloubeidi
    Digestive Diseases and Sciences, 2015, 60 : 3497 - 3497
  • [38] Rectal Indomethacin for Post-ERCP Pancreatitis Prophylaxis in Average Risk Patients: Too Early to Terminate and Too Early to Conclude
    Akshintala, Venkata S.
    Singh, Vikesh K.
    Reddy, Duvvuri Nageshwar
    GASTROENTEROLOGY, 2016, 151 (03) : 567 - 568
  • [39] Rectal Indomethacin to Prevent Post-ERCP Pancreatitis (vol 367, pg 277, 2012)
    Abu Dayyeh, Barham K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (11): : 1073 - 1073
  • [40] Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial
    Li, Zhao-Shen
    Pan, Xue
    Zhang, Wen-Jun
    Gong, Biao
    Zhi, Fa-Chao
    Guo, Xue-Gang
    Li, Pei-Ming
    Fan, Zhi-Ning
    Sun, Wen-Sheng
    Shen, Yun-Zhi
    Ma, Shu-Ren
    Xie, Wei-Fen
    Chen, Min-Hu
    Li, Yan-Qing
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (01): : 46 - 51
12345